Applied Filters
Wyeth secures Australian injunction against MSD vaccine
The Federal Court of Australia has granted Pfizer subsidiary Wyeth’s bid for an injunction against Merck Sharp Dohme in a dispute over vaccine patents.
Australian court issues mixed vaccine patent ruling
In a mixed decision for Merck Sharp Dohme, the Federal Court of Australia has concluded that the pharmaceutical company is infringing one patent owned by Wyeth, but that two other Wyeth patents are invalid.
Spruson & Ferguson promotes four to principal
Law firm Spruson & Ferguson has appointed four new principals across the firm as part of its 2020 promotions. The appointments have been made in the firm’s Hong Kong, Singapore, Sydney and Melbourne offices.
Children’s hospital researcher admits selling trade secrets to China
A former researcher at the research institute of the Nationwide Children’s Hospital in Ohio has pleaded guilty to conspiring to steal scientific trade secrets to sell in China.
Australian court affirms Mylan patent invalidation
The Federal Court of Australia has upheld a patent victory for Indian generic manufacturer Sun Pharma over Mylan in a dispute over cholesterol drug fenofibrate.
Roche and Innovent unite in $2bn biospecifics deal
Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies.
WHO launches COVID-19 pool with 37 countries
The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.
Australia investigates counterfeit N95s in hospitals
The Australian government has ordered an investigation into the sale of counterfeit face masks in the country, following warnings from health experts and local media reports over the prevalence of fake equipment.
WHO and Costa Rica to launch COVID-19 technology patent pool
The World Health Organization and Costa Rica will launch a technology pooling initiative to help fight the COVID-19 pandemic.
Setback for Gilead in GSK HIV antiviral suit
An Australian federal judge has thrown out a challenge by Gilead Sciences to the wording of infringement claims made by a GlaxoSmithKline subsidiary.
